6-K
WORK Medical Technology Group LTD (WOK)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of July 2025
Commission File Number: 001-42256
WORK Medical Technology Group LTD
Floor 23, No. 2 Tonghuinan Road
Xiaoshan District, Hangzhou City, Zhejiang Province,The People’s Republic of China
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F ☒ Form 40-F ☐
The authorized share capital of WORK Medical Technology Group LTD is US$250,000 divided into 400,000,000 Class A ordinary shares of par value US$0.0005 each, with each Class A ordinary share entitled to one vote, and 100,000,000 Class B ordinary shares of par value US$0.0005 each, with each Class B ordinary share entitled to 20 votes. As of July 15, 2025, 48,942,082 Class A ordinary shares and 7,592,500 Class B ordinary shares were issued and outstanding.
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| WORK Medical Technology Group LTD | ||
|---|---|---|
| Date: July 15, 2025 | By: | /s/ Shuang Wu |
| Name: | Shuang Wu | |
| Title: | Chief Executive Officer |
2